News
Covishield recipients in dilemma over second jab

By Shamindra Ferdinando
The Government Medical Officers’ Association (GMOA) yesterday (11) said that the ‘health administration’ hadn’t been able to reach a consensus on the second jab for those who received the Oxford-AstraZeneca (Covishield) vaccine first dose.
The government, both in and out of Parliament has acknowledged a shortfall of over 600,000 Covishield doses.
Top GMOA spokesperson Dr Naveen de Zoysa told The Island contrary to various statements made over the past several days in that regard, health authorities hadn’t been able to take a decision, in case ongoing efforts at government level to procure a sufficient stock, failed. Responding to another query, the outspoken GMOA official said that they were in a quandary.
When The Island pointed out that the success of the vaccination programme, depended on the availability of the second dose within 12 to 16 weeks after the first, Dr. Zoysa said that some expressed the view it would be better to have the same in spite of a slight delay. Then others talked of a ‘vaccine mix’ or vaccine cocktail’ to meet the requirement, Dr. Zoysa said. However, at the moment, the issue at hand hadn’t been addressed, the GMOA spokesperson said.
State Minister for Primary Health Care, Epidemic & Covid Disease Control Dr. Sudarshini Fernandopulle yesterday afternoon assured that the government was trying hard to obtain the required number of Oxford-AstraZeneca doses for the second jab.
The government launched the second round on April 28. The first round launched on January 29 was brought to an end on April 6.
GMOF (Government Medical Officers’ Forum) President Dr. Rukshan Bellana emphasized that the government owed an explanation to the public how it intended to solve the issue at hand. Responding to The Island queries, Dr. Bellana said that the very purpose of the vaccination programme would be jeopardized if over 600,000 people couldn’t receive the second jab.
Dr. Bellana urged the government to reveal its response to the crisis without further delay. “We know, Sri Lanka received approximately 1,264,000 covishield doses from India in three separate consignments. Of them, half a million were a donation. Having used 927,000 for the first dose, the country had about 330,000 at the time the government launched the second round. We are now faced with over 600,000 shortfall. That is the undeniable truth,” Dr. Bellana said.
The GMOF Chief said that the deepening health emergency in India shouldn’t be an excuse for those who turned a blind eye to the developing situation here. If the government made timely intervention, the situation wouldn’t have deteriorated so rapidly, Dr. Bellana said adding that the country was now paying a huge price for the government not taking tangible measures ahead of Sinhala and Tamil New Year.
Chief Epidemiologist Dr. Sudath Samaraweera didn’t answer his hand phone.
Dr. Bellana alleged that influential persons had jumped the queue to secure the second covishield jab. The GMOF urged the government to look into that matter and ensure transparency in the process.
The Island also sought an explanation from Chief of Vaccination Plan Lalith Weeratunga, who is also President Gotabaya Rajapaksa’s principal advisor regarding how the government intended to ensure the second jab. Weeratunga said that the government was in touch with three countries in that regard. “We are quite confident the required stock could be secured to meet the shortfall,” Weeratunga said, adding that in addition to 600,000 Sinopharm vaccines received from China free of charge, the country could get as much as 3 mn doses from Beijing. Referring to consensus with Russia to procure 13 mn doses, Weeratunga emphasized that Chinese and Russian vaccines were going to be Sri Lanka’s mainstay against the backdrop of the situation in India.
Weeratunga said that in spite of on and off setbacks, the government pursued a proper vaccination strategy. He said that the government was quite confident that by August-Sept a substantial percentage of people could be vaccinated.